CLINICAL VALIDATION OF UNANI PHARMACOPEIAL FORMULATION JAWARISH PUDINA WILAYATI IN THE MANAGEMENT OF SŪ’ AL-HAZM (DYSPEPSIA)

Abstract

Background: Dyspepsia is a sensation of discomfort in the upper part of abdomen usually starts immediately after having a meal. Patients usually reports stomach-ache, over-fullness, bloating and sometime acid reflux, heartburn, and excessive burping.

Aim: This study aims to validate the efficacy of 5g of Jawarish Pudina Wilayati in the Management of Sū’ al-Hazm (Dyspepsia) for a period of six weeks.

Method: Multicentric open label clinical study was strategized; 100 patients completed the 6 weeks protocol therapy from 18/08/2020 to 03/03/2022. 5 g of Jawarish Pudina Wilayati was given twice daily.

Result: 37% patients were completely relieved while 49% patients were partially relieved. Safrāvī patients aged between 29-39 years showed maximum response. No side effects were observed.

Conclusion: Jawarish Pudina Wilayati is safe and effective in the management of Sū’ al-Hazm (Dyspepsia)

Keyword: Sū’ al-Hazm, Dyspepsia, Jawarish, Unani, Quwat Jaziba, Fasad al-Hazm